July Cannabis Sales in 11 Markets Increased 4.6% From June to $1.69 Billion

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states.

Cannabis sales increased 4.6% in July compared to June according to cannabis data analytics firm BDSA. On a per-day basis, sales increased 1.2% sequentially. In this review, we will look at the markets one-by-one, beginning with the eastern markets and then concluding with the western markets. In total, sales across the 11 markets totaled $1.69 billion during the month.

Eastern Markets

BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan and Pennsylvania. In July, year-over-year growth ranged from -13.5% in Pennsylvania to 27.2% in Florida. Note that Florida, Maryland and Pennsylvania are medical-only markets.


In July, sales increased 0.8% sequentially to $193.8 million, up 27.2% from a year ago. Flower sales grew 23%, pre-rolls increased 11%, ingestibles gained 17% and concentrates expanded 39% year-over-year.


We previously published data released by the state showing that sales grew 6% from June and increased 1.6% from July 2021. BDSA estimated sales of $164.6 million, up 6% sequentially and up 0.6% from a year ago. Compared to last year, flower sales declined 3%, pre-rolls jumped 31%, ingestibles fell 5% and concentrates increased 2%.


Sales increased 2.5% from June to $42 million, down 10.7% from a year ago. Flower sales decreased 8%, pre-rolls declined 9% and concentrates fell 18%, while ingestibles were down 3% year-over-year.


Sales grew 9% sequentially and 5.2% compared to a year ago to $158.5 million. Flower and ingestibles sales expanded 7%, pre-rolls increased 8% and concentrates were flat compared to last year.


We had previously written about data released by the state indicating that Michigan cannabis sales gained 12% sequentially and 23% year-over-year. BDSA estimated sales of $209.9 million, up 12% sequentially and 20.5% from a year ago. Flower sales increased 24%, while concentrates grew 28%. Pre-rolls jumped 45% and ingestibles declined 4% compared to prior year.


Sales grew 0.5% in July to $95.3 million, down 13.5% compared to a year ago. Flower sales declined 11% year-over-year, concentrates fell 16%, while ingestibles were down 8%.

Western Markets

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In July, year-over-year growth ranged from -23.1% in Colorado to -10.1% in California compared to a year ago.


Combined sales of $107.5 million were up 1.4% from June and down 10.5% compared to July 2021. Medical sales of $43.6 million were up 2% sequentially and down 33% from a year ago. Adult-use sales of $63.9 million gained 1% from June and 15% year-over-year. Flower sales were down 25% from a year ago, while pre-rolls grew 38%. Concentrates fell 8% and ingestibles gained 5%.


California sales increased 2.2% sequentially to $409.6 million and fell 10.1% compared to a year ago. Flower sales were down 19%, while pre-rolls grew 6%. Ingestibles and concentrates fell 6% from a year ago during July.


Sales increased 6.7% in July compared to June, dropping 23.1% from a year ago to $156.2 million. Flower sales were down 25%, pre-rolls declined 21%, while concentrates fell 20%. Ingestibles declined 24% year-over-year.


Sales increased 6.9% sequentially, falling 14% from a year ago to $70.9 million. Flower sales dropped 21% from a year ago. Concentrates fell 1%, while ingestibles decreased 18% and pre-rolls declined 9%.


Sales in July grew 2% from June to $84.4 million, down 18.4% from a year ago. Flower sales were down 31% year-over-year. Ingestibles grew 8%, while pre-rolls declined 3% and concentrates decreased 17%. 

For readers interested in a deeper look at cannabis markets across these eleven states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with unlimited access to the most accurate and actionable data and analysis.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter